347 related articles for article (PubMed ID: 16490849)
1. Severe eczematous skin reaction after high-dose intravenous immunoglobulin infusion: report of 4 cases and review of the literature.
Vecchietti G; Kerl K; Prins C; Kaya G; Saurat JH; French LE
Arch Dermatol; 2006 Feb; 142(2):213-7. PubMed ID: 16490849
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulins-induced eczematous eruption: a long-term follow-up study.
Cohen Aubart F; Barete S; Amoura Z; Francès C; Lyon-Caen O; Lebrun-Vignes B
Eur J Intern Med; 2009 Jan; 20(1):70-3. PubMed ID: 19237096
[TBL] [Abstract][Full Text] [Related]
3. Pompholyx and eczematous reactions associated with intravenous immunoglobulin therapy.
Gerstenblith MR; Antony AK; Junkins-Hopkins JM; Abuav R
J Am Acad Dermatol; 2012 Feb; 66(2):312-6. PubMed ID: 21601310
[TBL] [Abstract][Full Text] [Related]
4. [Eczematous reactions after intravenous immunoglobulin therapy in two patients with Guillain-Barré syndrome and a patient with Miller Fisher syndrome].
Tada M; Tada M; Ishiguro H; Yagi E; Hirota K
No To Shinkei; 2003 May; 55(5):401-5. PubMed ID: 12833881
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin-induced, non-eczematous, vesiculobullous eruptions in Stevens-Johnson syndrome.
Lin WL; Lin WC; Chang YC; Yang LC; Hung SI; Hong HS; Chung WH
Am J Clin Dermatol; 2009; 10(5):339-42. PubMed ID: 19658448
[TBL] [Abstract][Full Text] [Related]
6. Eczema and X-linked agammaglobulinaemia.
Hunter HL; McKenna KE; Edgar JD
Clin Exp Dermatol; 2008 Mar; 33(2):148-50. PubMed ID: 18076688
[TBL] [Abstract][Full Text] [Related]
7. Dyshidrotic-like spongiotic dermatitis after intravenous immunoglobulin therapy.
Uyttendaele H; Obadiah J; Grossman M
J Drugs Dermatol; 2003 Jun; 2(3):337-41. PubMed ID: 12848120
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature.
Marie I; Maurey G; Hervé F; Hellot MF; Levesque H
Br J Dermatol; 2006 Oct; 155(4):714-21. PubMed ID: 16965420
[TBL] [Abstract][Full Text] [Related]
10. Safety of intravenous immunoglobulin (IVIG) therapy.
Katz U; Achiron A; Sherer Y; Shoenfeld Y
Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
[TBL] [Abstract][Full Text] [Related]
11. Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature.
Schiavotto C; Ruggeri M; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):35-40. PubMed ID: 8039756
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of intravenous immunoglobulin in Arndt-Gottron scleromyxedema].
Lopez L; Wierzbicka-Hainaut E; Villers A; Guillet G
Ann Dermatol Venereol; 2009 Apr; 136(4):330-6. PubMed ID: 19361699
[TBL] [Abstract][Full Text] [Related]
13. Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome.
Shiraishi T; Yamamoto T
Pediatr Dermatol; 2013; 30(3):e30-1. PubMed ID: 22304420
[TBL] [Abstract][Full Text] [Related]
14. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin.
Rütter A; Luger TA
J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915
[TBL] [Abstract][Full Text] [Related]
15. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobinuria and acute kidney injury requiring hemodialysis following intravenous immunoglobulin infusion.
Welles CC; Tambra S; Lafayette RA
Am J Kidney Dis; 2010 Jan; 55(1):148-51. PubMed ID: 19628320
[TBL] [Abstract][Full Text] [Related]
17. Effect of high-dose intravenous immunoglobulin treatment in therapy-resistant chronic spontaneous urticaria.
Mitzel-Kaoukhov H; Staubach P; Müller-Brenne T
Ann Allergy Asthma Immunol; 2010 Mar; 104(3):253-8. PubMed ID: 20377115
[TBL] [Abstract][Full Text] [Related]
18. Dyshidrotic eczema and seborrheic dermatitis-like eczematous eruption following intravenous immunoglobulin therapy.
Takci Z; Guler Simsek G; Uzuner H; Akbayrak A; Yıldız Seckin H; Karadag AS
Dermatol Ther; 2020 Nov; 33(6):e14147. PubMed ID: 32767429
[TBL] [Abstract][Full Text] [Related]
19. [Acute kidney failure secondary to intravenous immunoglobulin administration. 4 cases and review of the literature].
Decocq G; de Cagny B; Andréjak M; Desablens B
Therapie; 1996; 51(5):516-26. PubMed ID: 9138386
[TBL] [Abstract][Full Text] [Related]
20. [Exfoliative dermatitis as a side effect of intravenous immunoglobulin treatment].
Markvardsen LH; Jakobsen J
Ugeskr Laeger; 2011 Oct; 173(43):2725-6. PubMed ID: 22027232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
